Advanced

Can alpha-synuclein be targeted in novel therapies for Parkinson's disease?

Brundin, Patrik LU and Olsson, Roger LU (2011) In Expert Review of Neurotherapeutics 11(7). p.917-919
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Expert Review of Neurotherapeutics
volume
11
issue
7
pages
917 - 919
publisher
Future Drugs Ltd
external identifiers
  • wos:000293853900001
  • pmid:21721907
  • scopus:79959965774
ISSN
1744-8360
DOI
10.1586/ern.11.73
language
English
LU publication?
yes
id
9fb0fe2a-2bac-4284-a84e-23510f492229 (old id 2059149)
alternative location
http://www.ncbi.nlm.nih.gov/pubmed/21721907?dopt=Abstract
date added to LUP
2011-08-01 18:31:16
date last changed
2017-07-02 04:35:05
@article{9fb0fe2a-2bac-4284-a84e-23510f492229,
  author       = {Brundin, Patrik and Olsson, Roger},
  issn         = {1744-8360},
  language     = {eng},
  number       = {7},
  pages        = {917--919},
  publisher    = {Future Drugs Ltd},
  series       = {Expert Review of Neurotherapeutics},
  title        = {Can alpha-synuclein be targeted in novel therapies for Parkinson's disease?},
  url          = {http://dx.doi.org/10.1586/ern.11.73},
  volume       = {11},
  year         = {2011},
}